Jonathan Dixon
General Counsel at BIONANO GENOMICS, INC.
Net worth: 17 448 $ as of 2024-05-30
Profile
Jonathan Dixon is currently working as the Secretary & General Counsel at Bionano Genomics, Inc. He previously worked as the Legal Director at GeneOhm Sciences, Inc., and as an Associate General Counsel at Becton, Dickinson & Co. and CareFusion Corp.
He completed his undergraduate degree at Brigham Young University and his graduate degree at Lewis & Clark Law School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIONANO GENOMICS, INC.
0.03% | 2024-06-02 | 18,025 ( 0.03% ) | 17 448 $ | 2024-05-30 |
Jonathan Dixon active positions
| Companies | Position | Start |
|---|---|---|
| BIONANO GENOMICS, INC. | General Counsel | 2022-02-28 |
Former positions of Jonathan Dixon
| Companies | Position | End |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
| CAREFUSION CORPORATION | Corporate Officer/Principal | - |
GeneOhm Sciences, Inc.
 GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Director/Board Member | - |
Training of Jonathan Dixon
| Brigham Young University | Undergraduate Degree |
| Lewis & Clark Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BIONANO GENOMICS, INC. | Health Technology |
| BECTON, DICKINSON AND COMPANY | Health Technology |
| Private companies | 2 |
|---|---|
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Health Technology |
CareFusion Corp.
 CareFusion Corp. Medical DistributorsDistribution Services CareFusion Corp. engages in the manufactures of medical equipment and device. The company was founded on February 4, 2009 and is headquartered in San Diego, CA. | Distribution Services |
- Stock Market
- Insiders
- Jonathan Dixon
